CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 8. MAPK inhibition by PD98059 does not affect Fli-1 binding activity. EMSA was performed using nuclear extracts from Dami cells pretreated with PD98059 or SB202190 (data not shown) and subjected to PMA stimulation in the presence of anti-Fli-1 antibody as outlined in "Materials and Methods." The specific oligonucleotide-Fli-1 complexes are indicated by arrows labeled Fli-1. S, supershifted Fli-1 nuclear-protein complex; A, nonspecific nucleoprotein complex.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation